---
$id: https://graph.org.ai/products/commodity/51142527
$type: Product
source: UNSPSC
code: "51142527"
title: "Etilevodopa"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Etilevodopa

**UNSPSC Code**: 51142527
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiparkinsonian agent with the molecular formula C11H15NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 895X917GYE, chemically known as (-)-3,4-dihydroxy-l-phenylalanine, ethyl ester but generally known as etilevodopa, which bears US NIH Compound Identifier 170345. European Medicines Agency schedules Etilevodopa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02042MIG. The term ETILEVODOPA is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). Most nations schedule etilevodopa under HS 29225000 and SITC 51467. As of Q4 2014, ETILEVODOPA remains the US FDA Preferred Term for this commodity. Etilevodopa bears US NLM identifiers UMLS ID C1434556 and NCI Concept Code C81562. SMILES: CCOC(=O)C(CC1=CC(=C(C=C1)O)O)N.

